Aqualitas Inc., a Nova Scotia-based licensed producer, is launching a new service aimed at educating, assisting, and onboarding veterans from across Canada into the company’s online medical cannabis platform.
In partnership with Veterans For Healing, a Cape Breton-based organization founded and run by veterans, the program will offer personalized services and a curated line of medical cannabis products that may be beneficial in treating post-traumatic stress disorder (PTSD), pain and other conditions that disproportionately impact veterans.
“Compassionate, supportive access to medical cannabis is a right that all Canadians should have,” Myrna Gillis, CEO and founding director of Aqualitas, said in a statement. “It is our responsibility and our privilege to work alongside Veterans for Healing to make this a reality for the veteran patient community. ”
According to Veterans Affairs Canada, up to 10 per cent of war zone veterans — including war-service veterans and peacekeeping forces — will experience PTSD.
“Over the years the veteran community has made it clear that they need and deserve a reliable supply of consistent quality medical cannabis and a supportive client care team,” Rob Gowans, CEO of Veterans For Healing said in a statement. “Our collaboration with Aqualitas is a powerful way to deliver this medicine to veterans and to work as part of a team with a truly patient-centred licensed producer to further assist veterans on their healing journey.”
The AQ-Together Veterans Program is now accepting registrations.
A number of other Canadian cannabis companies offer programs for veterans, including Canopy Growth. Its Veteran Care program operates through the company’s medical division, Spectrum Therapeutics, and, among other benefits, covers the cost of any Health Canada-approved vaporizer for qualifying patients.
Ontario-based Avail Cannabis also operates veteran assistance clinics, covering medical cannabis prescriptions, vaporizers, and other services, and notes that the most common qualifying conditions are PTSD and chronic pain.
The company is currently conducting an observational study focused on PTSD among Canadian vets that aims to identify the “optimal cannabinoid profile and therapeutic dose of medical cannabis oil.”
Canadian Forces veteran Scott Atkinson is an ambassador with Ontario-based CannaConnect, a medical cannabis company that helps veterans understand and access medical cannabis treatment. His success with medical cannabis also pushed him toward pursuing psychedelic therapy.
Atkinson recently spoke to The GrowthOp about his success in treating post-traumatic stress disorder, depression, anxiety and chronic pain with ketamine-assisted psychotherapy.
He said both cannabis and psychedelic therapy are needed services among Canada’s vet population.
“It’s amazing how many people are interested,” he said. “On the physical and mental health side of it, it could possibly put people in a spot where they don’t need a certain medication.”
Subscribe to Weekend Dispensary, a new weekly newsletter from The GrowthOp.